User profiles for Harald H. Sitte
Harald H. SitteProfessor of Psychopharmacology, Medical University Vienna Verified email at meduniwien.ac.at Cited by 10728 |
[HTML][HTML] Powerful cocaine-like actions of 3, 4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products
The abuse of psychoactive ‘bath salts’ containing cathinones such as 3, 4-methylenedioxypyrovalerone
(MDPV) is a growing public health concern, yet little is known about their …
(MDPV) is a growing public health concern, yet little is known about their …
[HTML][HTML] Amphetamines, new psychoactive drugs and the monoamine transporter cycle
HH Sitte, M Freissmuth - Trends in pharmacological sciences, 2015 - cell.com
In monoaminergic neurons, the vesicular transporters and the plasma membrane transporters
operate in a relay. Amphetamine and its congeners target this relay to elicit their actions: …
operate in a relay. Amphetamine and its congeners target this relay to elicit their actions: …
[PDF][PDF] Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport
Efflux of dopamine through the dopamine transporter (DAT) is critical for the psychostimulatory
properties of amphetamines, but the underlying mechanism is unclear. Here we show that …
properties of amphetamines, but the underlying mechanism is unclear. Here we show that …
[HTML][HTML] Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation
Shock wave treatment accelerates impaired wound healing in diverse clinical situations.
However, the mechanisms underlying the beneficial effects of shock waves have not yet been …
However, the mechanisms underlying the beneficial effects of shock waves have not yet been …
[HTML][HTML] Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in …
…, O Kudlacek, M Freissmuth, EA Singer, HH Sitte - Journal of Biological …, 2001 - ASBMB
Recent biochemical studies indicate that the serotonin transporter can form oligomers. We
investigated whether the human serotonin transporter (hSERT) can be visualized as an …
investigated whether the human serotonin transporter (hSERT) can be visualized as an …
Actovegin®: a biological drug for more than 5 decades.
…, MW Elmlinger, G Lauer, G Nell, HH Sitte - Wiener Medizinische …, 2011 - europepmc.org
Actovegin (®) is a biological drug manufactured from a natural source: it is a calf blood
hemodialysate. Its therapeutic benefits stem from a variety of pharmacodynamic actions that can …
hemodialysate. Its therapeutic benefits stem from a variety of pharmacodynamic actions that can …
[HTML][HTML] Missense dopamine transporter mutations associate with adult parkinsonism and ADHD
Parkinsonism and attention deficit hyperactivity disorder (ADHD) are widespread brain
disorders that involve disturbances of dopaminergic signaling. The sodium-coupled dopamine …
disorders that involve disturbances of dopaminergic signaling. The sodium-coupled dopamine …
Anomalous dopamine release associated with a human dopamine transporter coding variant
…, M Schmudermaier, M Freissmuth, HH Sitte… - Journal of …, 2008 - Soc Neuroscience
Dopamine (DA) signaling at synapses is tightly coordinated through opposing mechanisms
of vesicular fusion-mediated DA release and transporter-mediated DA clearance. Altered …
of vesicular fusion-mediated DA release and transporter-mediated DA clearance. Altered …
Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3
Uptake through the dopamine transporter (DAT) represents the primary mechanism used to
terminate dopaminergic transmission in brain. Although it is well known that dopamine (DA) …
terminate dopaminergic transmission in brain. Although it is well known that dopamine (DA) …
[HTML][HTML] The N terminus of monoamine transporters is a lever required for the action of amphetamines
The serotonin transporter (SERT) terminates neurotransmission by removing serotonin from
the synaptic cleft. In addition, it is the site of action of antidepressants (which block the …
the synaptic cleft. In addition, it is the site of action of antidepressants (which block the …